Rheumatology · North Hollywood, CA
NPI
1992780225
Since 2005
Specialty
Rheumatology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
12660 Riverside Dr, Suite 200
North Hollywood, CA, 91607
Phone (818) 980-7010
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.2M
252,117 services
Medicare patients, 2024
757
Average age 76
Drug cost, 2024
$2.4M
3,323 prescriptions
Company payments, 2025
$3,621
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Wonil Lee was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 94,007 times for 32 patients. In total Wonil Lee billed 252,117 services in 62 codes, and Medicare paid $2.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-09-17.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 94,007 | 32 | $2.55 | $240K |
| J3111 Injection, romosozumab-aqqg, 1 mg | Office | 51,661 | 43 | $7.72 | $399K |
| J3262 Injection, tocilizumab, 1 mg | Office | 38,682 | 12 | $3.67 | $142K |
| J0897 Injection, denosumab, 1 mg | Office | 24,300 | 249 | $18.30 | $445K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 13,239 | 120 | $0.10 | $1,360 |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 2,980 | 12 | $24.98 | $74K |
| 99214 Office E&M - Established | Office | 2,303 | 673 | $107.74 | $248K |
| 96401 Chemotherapy Administration | Office | 1,371 | 307 | $64.55 | $88K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,080 | 445 | $13.30 | $14K |
| 96413 Chemotherapy Administration | Office | 337 | 50 | $119.44 | $40K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 329 | 50 | $0.50 | $166 |
| 20611 Joint Injection | Office | 247 | 99 | $83.76 | $21K |
| 36415 Venipuncture Blood Collection | Office | 241 | 208 | $8.65 | $2,085 |
| 96415 Chemotherapy Administration | Office | 240 | 28 | $25.18 | $6,044 |
| 99204 Office E&M - New | Office | 144 | 144 | $132.87 | $19K |
By year: 2022 $1.6M for 151,041 services; 2023 $1.8M for 167,702 services; 2024 $2.2M for 252,117 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 241 | 208 | $8.65 | $2,085 |
Medicare prescription drug claims, 2024
In 2024, the drug Wonil Lee prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 337 prescriptions and refills. In total Wonil Lee wrote 3,323 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 337 | 646 | 82 | $9,475 |
| Prednisone Generic | 311 | 369 | 70 | $2,412 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 300 | 300 | 43 | $7,719 |
| Hydroxychloroquine Sulfate Generic | 230 | 408 | 58 | $8,036 |
| Gabapentin Generic | 141 | 270 | 32 | $1,697 |
| Meloxicam Generic | 110 | 144 | 33 | $476 |
| Zolpidem Tartrate Generic | 105 | 127 | 18 | $589 |
| Celecoxib Generic | 98 | 168 | 26 | $3,986 |
| Tramadol Hcl Generic | 90 | 90 | 23 | $550 |
| Colchicine Generic | 85 | 125 | 31 | $3,901 |
| Cimzia (2 Pack) Certolizumab Pegol | 83 | 87 | 11 | $489K |
| Enbrel Sureclick Etanercept | 73 | 79 | Under 11 | $539K |
| Prolia Denosumab | 72 | 413 | 44 | $125K |
| Allopurinol Generic | 71 | 159 | 18 | $608 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 68 | 78 | 12 | $2,463 |
Brand drugs: - claims; generic drugs: 2,838 claims; opioid claims: 524.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Wonil Lee $3,621 ($3,621 in general payments such as food, travel and fees) from 21 companies. The largest payer was Amgen Inc. with $721.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 31 | $721 |
| Novartis Pharmaceuticals Corporation NVS | 22 | $585 |
| Abbvie Inc. ABBV | 20 | $538 |
| Pfizer Inc. PFE | 9 | $279 |
| Janssen Biotech, Inc. JNJ | 7 | $215 |
| TerSera Therapeutics LLC | 5 | $183 |
| UCB, Inc. UCB.BR | 5 | $164 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $158 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $151 |
| Organon LLC OGN | 6 | $136 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.